NCT04672083 - A Clinical Study of the HIV Drug CPT31 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

April 26, 2021

Study Completion Date

April 29, 2021

Conditions

HIV Infections

Interventions

DRUG

CPT31

CPT31 (cholesterol-PIE12-2-trimer) is a novel D-peptide HIV entry inhibitor that binds with high affinity to a conserved hydrophobic pocket within the gp41 trimer

DRUG

Placebo

matching placebo

Trial Locations (1)

32117

Covance Clinical Research Unit Inc., Daytona Beach